AS
EXAS

AM Squared’s Exact Sciences EXAS Stock Holding History

AM Squared’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,800
Closed -$76K – 77
2024
Q2 		$76K Buy
+1,800
New +$99K 0.19% 43

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AM Squared's EXAS Position: Q3 2024 in Review

AM Squared sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 1,800 shares — an estimated $76K sold.

AM Squared first reported a position in EXAS in Q2 2024 and held it in 1 quarter. The position peaked at $76K in Q2 2024. 600 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

  • AM Squared reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
  • AM Squared sold 1,800 Exact Sciences shares in Q3 2024, an estimated $76K.
  • AM Squared first reported a position in Exact Sciences in Q2 2024 and held it in 1 quarter.
  • AM Squared's Exact Sciences position peaked at $76K in Q2 2024.
  • 600 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on AM Squared's 13F filing for Q3 2024, filed 7 Nov 2024.